Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Dermata Therapeutics, Inc. - Common Stock
(NQ:
DRMA
)
2.370
+0.330 (+16.18%)
Streaming Delayed Price
Updated: 1:00 PM EST, Dec 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dermata Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Why Did Dermata Therapeutics Stock Surge 22% Pre-Market Today?
↗
December 24, 2025
The company has entered into definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal.
Via
Stocktwits
These stocks that are showing activity before the opening bell on Wednesday.
↗
December 24, 2025
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
December 24, 2025
Via
ACCESS Newswire
These stocks are moving in today's after hours session
↗
December 05, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity
December 04, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
November 20, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
November 19, 2025
Via
Benzinga
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
November 14, 2025
Via
ACCESS Newswire
Unusual volume stocks are being observed in Wednesday's session.
↗
October 08, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 07, 2025
Via
Benzinga
Unusual volume stocks are being observed in Tuesday's session.
↗
October 07, 2025
On Tuesday, there are stocks with unusual volume. Let's take a look.
Via
Chartmill
Which stocks are moving on Tuesday?
↗
October 07, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
October 07, 2025
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 07, 2025
Via
Benzinga
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
↗
October 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 06, 2025
Via
Benzinga
Wondering what's happening in today's after-hours session?
↗
October 06, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office
October 02, 2025
Via
ACCESS Newswire
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
September 18, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Dermata Therapeutics Announces Presentation of Abstract at the European Academy of Dermatology and Venereology Congress 2025
September 17, 2025
Via
ACCESS Newswire
Life Science Virtual Investor Forum Agenda Announced for September 18th
September 16, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th
September 16, 2025
Dermata invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments
September 10, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 03, 2025
Via
Benzinga
Dermata Posts Narrower Loss in Q2
↗
August 13, 2025
Via
The Motley Fool
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
August 13, 2025
Via
ACCESS Newswire
Dermata Receives Notice of Grant of Australian Patent for Topical Botulinum Toxin Treatment for Hyperhidrosis
July 08, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 07, 2025
Via
Benzinga
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
May 14, 2025
Via
ACCESS Newswire
Dermata’s XYNGARI(TM) Phase 3 Trial Hits Statistically Significant Difference at 4 Weeks
April 15, 2025
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
